Sequences

Sample result

GFP, read as protein

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

4,303 publications in 2,986 families match these filters.

  1. JP 2023543202-A2023-10-13

    NUCLEIC ACID MOLECULE TARGETING MUTATION SITE OF CYP4V2 GENE AND USE THEREOF

    CHIGENOVO CO LTD

    Identity 97.9%

    Best alignment

    Query 1 to 238, hit 1 to 714. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 180
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 360
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   361 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 540
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||| |||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   541 HYQQNAPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 714
    

    233 of 238 identical, no gaps.

  2. US 11788093-B22023-10-17

    Chimeric antigen receptor t-cells expressing interleukin-8 receptor

    University of Florida Research Foundation, Inc.

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1242 to 1955. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1242 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1421
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1422 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1601
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1602 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1781
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1782 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1955
    

    234 of 238 identical, no gaps.

  3. US 11788205-B22023-10-17

    Car-t cell assay for specificity test of novel antigen binding moieties

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1435 to 2148. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1435 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1614
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1615 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1794
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1795 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1974
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1975 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 2148
    

    234 of 238 identical, no gaps.

  4. JP 2023544325-A2023-10-23

    COMPOSITION FOR PREVENTING OR TREATING NEUROPSYCHOLOGIC DISEASE, COMPRISING MANF

    CEFO CO LTD

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 717 to 4. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   717 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 538
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   537 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 358
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   357 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 178
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   177 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 4
    

    234 of 238 identical, no gaps.

  5. JP 2023544326-A2023-10-23

    COMPOSITION INCLUDING PLGF FOR PREVENTION OR TREATMENT OF NEUROPSYCHOLOGIC DISEASE

    CEFO CO LTD

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 717 to 4. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   717 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 538
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   537 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 358
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   357 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 178
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   177 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 4
    

    234 of 238 identical, no gaps.

  6. JP 2023544633-A2023-10-24

    REPLACEMENT OF RAG1 FOR USE IN THERAPY

    OSPEDALE SAN RAFFAELE S R L,FONDAZIONE TELETHON

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 831 to 1544. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    831 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1010
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1011 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1190
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1191 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1370
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1371 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1544
    

    234 of 238 identical, no gaps.

  7. JP 2023544894-A2023-10-25

    PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RETINAL OR CHOROIDAL DISEASE COMPRISING PLVAP AS ACTIVE INGREDIENT

    THE ASAN FOUNDATION,UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION

    Identity 97.9%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||| |||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    233 of 238 identical, no gaps.

  8. WO 2023204313-A2023-10-26

    Patent application sequence for WO 2023204313-A/10

    Applicants [Refer to the patent publication]

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  9. JP 2023545864-A2023-10-31

    Fluorescent Fusion Based Heterologous Peptide Production

    Stellenbosch University

    Identity 96.6%Family of 2

    Best alignment and family

    Query 1 to 238, hit 43 to 756. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
              |||||||||||||||||||||||| |||||||||||||||||||||||||||||||||||
    Hit    43 MSKGEELFTGVVPILVELDGDVNGYKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 222
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||| ||||||||||||||||||||||||||||||||||||||||
    Hit   223 VTTLTYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 402
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||||||||||||||||||||| ||| ||||||| |||||
    Hit   403 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKANFKTRHNIEDGGVQLAD 582
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||| |||||||||||||||||||||||||||||||||||||||||||||||
    Hit   583 HYQQNTPIGDDPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 756
    

    230 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  10. US 11802269-B22023-10-31

    Superpiggybac transposase compositions

    Poseida Therapeutics, Inc.

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1399 to 2112. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1399 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1578
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1579 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1758
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1759 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1938
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1939 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 2112
    

    234 of 238 identical, no gaps.

  11. JP 2023546202-A2023-11-01

    Method for manufacturing HEK293 cell line, method for manufacturing EB-VLPs and composition comprising said EB-VLPs

    Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  12. WO 2023210616-A2023-11-02

    Chimeric envelope proteins of RNA virus and RNA virus vectors having the same

    TOKIWA-BIO INC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 101 to 814. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   101 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 280
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   281 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 460
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   461 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 640
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   641 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 814
    

    234 of 238 identical, no gaps.

  13. WO 2023210661-A2023-11-02

    Composition and use thereof, for activating CAR-T cells; proliferating hematopoietic stem cells; and regulating differentiation of iPS cells

    NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 1657 to 2370. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1657 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1836
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1837 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 2016
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2017 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 2196
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   2197 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 2370
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, JP 2022-071611.

  14. ENGINEERED EXPRESSION CONSTRUCTS TO INCREASE PROTEIN EXPRESSION FROM SYNTHETIC RIBONUCLEIC ACID (RNA)

    RIBOZ, LLC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 24 to 737. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    24 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 203
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   204 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 383
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   384 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 563
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   564 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 737
    

    234 of 238 identical, no gaps.

  15. US 11807867-B22023-11-07

    Compositions and methods for treating non-age-associated hearing impairment in a human subject

    Akouos, Inc.

    Identity 98.3%Family of 3

    Best alignment and family

    Query 1 to 238, hit 908 to 1621. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    908 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1087
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1088 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1267
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1268 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1447
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1448 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1621
    

    234 of 238 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  16. COMPOSITIONS AND METHODS FOR TREATING SKELETAL MUSCLE DISEASE

    YALE UNIVERSITY

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  17. WO 2023214578-A2023-11-09

    Virus-derived construct plasmid library and construction thereof

    Synplogen Co., Ltd

    Identity 98.2%

    Best alignment

    Query 18 to 238, hit 9 to 671. Positions start at 1 and include both ends.

    Query  18 LDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFSRYPDH 77
               |||||||||||||||||||||||||||||||||||||||||||||  ||||||||||||
    Hit     9 IDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDH 188
    
    Query  78 MKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNIL 137
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   189 MKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNIL 368
    
    Query 138 GHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPD 197
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   369 GHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPD 548
    
    Query 198 NHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||| |||||||
    Hit   549 NHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 671
    

    217 of 221 identical, no gaps.

  18. WO 2023214579-A2023-11-09

    Virus-derived construct plasmid

    Synplogen Co., Ltd

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 119 to 832. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   119 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 298
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   299 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 478
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   479 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 658
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   659 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 832
    

    234 of 238 identical, no gaps.

  19. JP 2023547681-A2023-11-13

    Viral vectors and nucleic acids for use in the treatment of ILD, PF-ILD and IPF

    Boehringer Ingelheim International GmbH

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 636 to 1349. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    636 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 815
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    816 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 995
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    996 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1175
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1176 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1349
    

    234 of 238 identical, no gaps.

  20. JP 2023547785-A2023-11-14

    prion-fc region fusion proteins and use thereof

    TOOLGEN INCORPORATED

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  21. JP 2023547887-A2023-11-14

    SAFE HARBOR LOCI

    ARSENAL BIOSCIENCES INC

    Identity 97.9%

    Best alignment

    Query 1 to 238, hit 520 to 1233. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    520 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 699
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    700 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 879
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    880 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1059
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               ||||||||||||||||||||||||| |||||||||||||||||||||||| |||||||
    Hit   1060 HYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1233
    

    233 of 238 identical, no gaps.

  22. LENTIVIRAL VECTORS TARGETING ANTIGENS TO MHC-II PATHWAY AND INDUCING PROTECTIVE CD8+ AND CD4+ T-CELL IMMUNITY IN A HOST

    INSTITUT PASTEUR

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  23. US 11814627-B22023-11-14

    Circular RNAs and their use in immunomodulation

    THE BOARD OF THE LELAND STANFORD JUNIOR UNIVERSITY and EMORY UNIVERSITY

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  24. JP 2023548208-A2023-11-15

    Viral vectors and nucleic acids for use in the treatment of ILD, PF-ILD and IPF

    Boehringer Ingelheim International GmbH

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 636 to 1349. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    636 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 815
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    816 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 995
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    996 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1175
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1176 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1349
    

    234 of 238 identical, no gaps.

  25. JP 2023548209-A2023-11-15

    Viral vectors and nucleic acids for use in the treatment of ILD, PF-ILD and IPF

    Boehringer Ingelheim International GmbH

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 636 to 1349. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    636 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 815
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    816 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 995
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    996 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1175
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1176 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1349
    

    234 of 238 identical, no gaps.

  26. N-(2-AMINOETHYL)MORPHOLINE-BASED RNA ANALOGS, METHOD FOR THE PREPARATION AND USE THEREOF

    UNIWERSYTET WARSZAWSKI

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 18 to 731. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    18 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 197
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   198 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 377
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   378 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 557
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   558 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 731
    

    234 of 238 identical, no gaps.

  27. MULTIPLEX EDITING WITH CAS ENZYMES

    METAGENOMI, INC

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 980 to 1693. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    980 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1159
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1160 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1339
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1340 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1519
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1520 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1693
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  28. Methods for producing Glutathione-S-Transferase fusion therapeutic protein in knock-in cell

    INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 633 to 1346. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    633 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 812
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    813 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 992
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    993 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1172
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1173 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1346
    

    234 of 238 identical, no gaps.

  29. METHOD TO ASSESS POTENCY OF VIRAL VECTOR PARTICLES

    Juno Therapeutics, Inc

    Identity 97.9%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||| |||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    233 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  30. CHIMERIC, TRANSMEMBRANE PROTEINS WITH BIDIRECTIONAL SIGNALLING ACTIVITY

    GADETA B.V

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  31. US 11820990-B22023-11-21

    Method for base editing in plants

    INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY, CHINESE ACADEMY OF SCIENCES

    Identity 98.7%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| ||| |||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTFTYGV*CFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 717
    

    235 of 238 identical, no gaps.

  32. WO 2023224102-A2023-11-23

    Novel Staple Nucleic Acid

    NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY

    Identity 97.1%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||  |||||||| |||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVVGDGDVNGHK*SVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    231 of 238 identical, no gaps.

  33. JP 2023549536-A2023-11-27

    CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE

    eGenesis Inc,Wenning Qin,Yinan Kan,Juliet Crabtree,Michele Youd,David Heja, David Angeles,Ranjith Anand,Paola Perrat,Russel Ernst,Jacob Layer, Violette Paragas

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  34. Gene expression particle based on metal nanoparticle-nucleic acid conjugate and manufacturing method thereof

    NES Biotechnology Co., Ltd

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 686 to 1399. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    686 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 865
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    866 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1045
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1046 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1225
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1226 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1399
    

    234 of 238 identical, no gaps.

  35. JP 2023549592-A2023-11-28

    Oligonucleotides for synthesizing 5'-capped RNA

    ST Pharm Co Ltd

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 72 to 785. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    72 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 251
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   252 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 431
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   432 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 611
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   612 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 785
    

    234 of 238 identical, no gaps.

  36. JP 2023550143-A2023-11-30

    Light-controlled viral transduction

    Albert-Ludwigs-Universitaet Freiburg

    Identity 95.4%

    Best alignment

    Query 1 to 238, hit 94 to 807. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||
    Hit    94 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLPVPWPTL 273
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  || ||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   274 VTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 453
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||||||||||| ||||||||| ||||||||||| |||||
    Hit   454 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLAD 633
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||| ||||||||||||||||||||||||||| |||||||
    Hit   634 HYQQNTPIGDGPVLLPDNHYLSYQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 807
    

    227 of 238 identical, no gaps.

  37. Target protein expression platform using virus nucleocapsid

    VAXDIGM Co., Ltd.

    Identity 99.6%

    Best alignment

    Query 2 to 238, hit 1 to 711. Positions start at 1 and include both ends.

    Query   2 SKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLV 61
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 SKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLV 180
    
    Query  62 TTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVN 121
              |||||||||||||||||| |||||||||||||||||||||||||||||||||||||||||
    Hit   181 TTFSYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVN 360
    
    Query 122 RIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADH 181
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   361 RIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADH 540
    
    Query 182 YQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   541 YQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 711
    

    236 of 237 identical, no gaps.

  38. COMPOSITIONS AND METHODS FOR MODIFYING GENOMES USING CPF1 OR CSM1

    BENSON HILL BIOSYSTEMS, INC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  39. US 11834648-B22023-12-05

    Human induced pluripotent stem cell lines for modeling Alzheimer's disease and usage thereof

    Shenzhen Cell Inspire Biotechnology Co., Ltd.

    Identity 96.6%

    Best alignment

    Query 1 to 238, hit 82 to 795. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    82 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 261
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   262 VTTLTYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 441
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||||||| ||| ||||||||||||| |||||||||||||
    Hit   442 NRIELKGIDFKEDGNILGHKLEYNYNSHKVYITADKQKNGIKVNFKTRHNIEDGSVQLAD 621
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   622 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 795
    

    230 of 238 identical, no gaps.

  40. JP 2023551047-A2023-12-06

    VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION THEREOF

    UNIVERSITY OF DUNDEE

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1156 to 1869. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1156 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1335
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1336 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1515
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1516 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1695
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1696 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1869
    

    234 of 238 identical, no gaps.

  41. JP 2023551479-A2023-12-08

    ADIPOGENIC CELL COMPOSITIONS AND METHODS

    Flagship Pioneering Inc,Sophie DE BOER,Le P NGO,Avak KAHVEJIAN, Jordan LEWANDOWSKI

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  42. JP 2023551513-A2023-12-08

    DNA constructs comprising alternative promoters

    ETH Zuerich

    Identity 96.6%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| ||  || ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTFGYGLMCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||| || |||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    230 of 238 identical, no gaps.

  43. JP 2023551533-A2023-12-08

    ANTI-VEGF ANTIBODY CONSTRUCTS AND RELATED METHODS FOR TREATING VESTIBULAR SCHWANNOMA ASSOCIATED SYMPTOMS

    AKOUOS INC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 3383 to 4096. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   3383 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 3562
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   3563 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 3742
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   3743 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 3922
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   3923 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 4096
    

    234 of 238 identical, no gaps.

  44. Sensor for glutamine detection using split glutamine-binding protein and use thereof

    KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

    Identity 95.4%

    Best alignment

    Query 1 to 238, hit 1 to 714. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
              ||||||||||||||||||||||||||||| |||||||| |||||||||||||||||||||
    Hit     1 MSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLPVPWPTL 180
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  ||||||||||||||||||||||||||||||||| ||||| |||||||||||||||
    Hit   181 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLV 360
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||| ||||||| ||||||||| ||||||| |||||||||
    Hit   361 NRIELKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGIKANFKIRHNVEDGSVQLAD 540
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||
    Hit   541 HYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 714
    

    227 of 238 identical, no gaps.

  45. JP 2023552998-A2023-12-20

    METHODS OF ENGINEERING IMMUNE CELLS FOR ENHANCED POTENCY AND PERSISTENCE AND USES OF ENGINEERED CELLS IN IMMUNOTHERAPY

    Nkarta Inc

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 946 to 1659. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    946 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1125
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1126 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1305
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1306 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1485
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1486 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1659
    

    234 of 238 identical, no gaps.

  46. JP 2023553341-A2023-12-21

    YEAST-BASED EXPRESSION OF THERAPEUTIC PROTEINS IN VIVO

    ESPEROVAX INC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 10 to 723. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    10 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 189
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   190 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 369
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   370 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 549
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   550 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 723
    

    234 of 238 identical, no gaps.

  47. JP 2023181909-A2023-12-25

    Fusion protein, Double-stranded DNA labeling agent, Double-stranded DNA labeling kit, DNA, and Vector

    Tokyo Denki University

    Identity 93.7%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||| |||||||| |||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| ||| ||||||||||||||||||||||||||||| ||||| |||||||||||||||
    Hit   184 VTTFGYGVACFSRYPDHMKQHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||| ||| ||| |||||| || ||||||| |||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNFNSHYVYITADKQKNCIKANFKIRHNVEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||| || ||||||||||||||||||||||||||||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSHQSKLSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 717
    

    223 of 238 identical, no gaps.

  48. CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE

    EGENESIS, INC

    Identity 98.3%Family of 3

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  49. ENGINEERING B CELL-BASED PROTEIN FACTORIES TO TREAT SERIOUS DISEASES

    WALKING FISH THERAPEUTICS, INC

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 676 to 1389. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    676 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 855
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    856 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1035
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1036 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1215
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1216 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1389
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  50. Recombinant expression vector comprising a guard cell-specific promotor and nucleic acid sequence encoding a protein that can induce constitutive stomatal opening, and plant transformed using the same

    KONGJU NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION

    Identity 99.2%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTFTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 717
    

    236 of 238 identical, no gaps.